BPG is committed to discovery and dissemination of knowledge
Articles in Press
3/27/2024 4:53:45 AM | Browse: 34 | Download: 0
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 89309
Country China
Category Biochemistry & Molecular Biology
Manuscript Type Basic Study
Article Title Complement factor I knockdown inhibits colon cancer development by affecting Wnt/β-catenin/c-Myc signaling pathway and glycolysis
Manuscript Source Unsolicited Manuscript
All Author List Yong-Jun Du, Yue Jiang, Yan-Mei Hou and Yong-Bo Shi
Funding Agency and Grant Number
Corresponding Author Yong-Bo Shi, MM, Associate Chief Physician, Department of Proctology, Zigong Hospital of Traditional Chinese Medicine, No. 59 Machongkou Street, Da’an District, Zigong 643000, Sichuan Province, China. syb821004@163.com
Key Words Colon cancer; Immune infiltration; Complement factor I; Glycolysis; Wnt/β-catenin/c-Myc pathway
Core Tip We identified six hub immune infiltration-related differentially expressed genes, of which the expression of complement factor I (CFI), complement factor B, lymphoid enhancer binding factor 1, and SRY-related high-mobility-group box 4 were upregulated, whereas that of fatty acid-binding protein 1 and bone morphogenic protein-2 were downregulated. CFI knockdown inhibited HT29 and HCT116 cell proliferation, migration, invasion, and tumor growth in a colon cancer (CC) mouse model constructed from HT29 cells. CFI knockdown suppressed the expression of glycolysis-related proteins (glucose transporter type 1, hexokinase 2, lactate dehydrogenase A, and pyruvate kinase M2) and Wnt/β-catenin/c-Myc-related protein-expression levels (β-catenin and c-Myc). CFI knockdown suppressed glycolysis by inhibiting the Wnt/β-catenin/c-Myc signaling pathway. These findings delineate a potential therapeutic strategy for the clinical management of CC.
Citation Du YJ, Jiang Y, Hou YM, Shi YB. Complement factor I knockdown inhibits colon cancer development by affecting Wnt/β-catenin/c-Myc signaling pathway and glycolysis. World J Gastrointest Oncol 2024; In press
Received
2023-10-27 07:05
Peer-Review Started
2023-10-27 07:06
To Make the First Decision
Return for Revision
2024-01-06 07:17
Revised
2024-01-24 08:05
Second Decision
2024-03-27 02:35
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2024-03-27 04:53
Articles in Press
2024-03-27 04:53
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com